Cryoport Inc. (NASDAQ: CYRX) disclosed that Chief Scientific Officer Mark W. Sawicki sold 1,341 shares of common stock on March 23, 2026, a Form 4 filing with the Securities and Exchange Commission shows. The shares were transacted at $8.18 apiece, producing a total sale amount of $10,969.
Following the sale, Sawicki retains direct ownership of 102,356 shares of Cryoport. The company states the disposition was executed to satisfy tax obligations stemming from the vesting of restricted stock rights, in line with issuer policies governing such events.
At the time of reporting, Cryoport's stock trades at $8.41 and the company carries a market capitalization of $417.79 million.
Recent operational and market context
Cryoport reported fourth-quarter 2025 revenue of $45.45 million, exceeding the $42.93 million that analysts had expected. That revenue result represents a positive surprise of 5.87% relative to forecasted sales. However, the company's earnings per share for the quarter fell short of consensus estimates, at -$0.27 versus an expected -$0.21, constituting a 28.57% miss. Despite the top-line beat, the stock declined in aftermarket trading following the release.
An InvestingPro Fair Value assessment cited in available research indicates Cryoport appears overvalued at its current trading level. The InvestingPro platform also provides a Pro Research Report on CYRX as part of its broader coverage of U.S. equities.
What the filing shows
- Insider: Mark W. Sawicki, Chief Scientific Officer
- Date of transaction: March 23, 2026
- Shares sold: 1,341
- Sale price per share: $8.18
- Total transaction value: $10,969
- Shares owned after sale: 102,356
- Reason provided: to cover tax obligations arising from vesting of restricted stock rights
The facts in the filing and the company’s quarterly results together sketch a mixed picture: a modest insider sale conducted for tax purposes and an earnings release that combined a revenue beat with an EPS shortfall, followed by a negative aftermarket reaction and a valuation note from InvestingPro.